Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram

Aleafia Health Inc. (TSX ALEF)
Published on: November 11, 2019
  • Cannabinoid content per gram only slightly lower than identical strains grown indoors
  • Critical quality control tests successful
  • Approximately 1,000 kg yield per acre in Zone 1
  • Expanded 3.7M sq. ft. outdoor site expected to produce approximately 102,000 kg in 2020 at full capacity

TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to report that Aleafia Farms Inc., its wholly owned subsidiary, produced an inaugural Port Perry Outdoor Grow harvest yielding approximately 10,300 kg of dried flower. The yield figure is limited to dried flower, and excludes stems or other parts of the cannabis plant.

“Today, we can definitively say that Aleafia Health is among the lowest-cost producers, while realizing close to the highest revenue per gram sold among our peers as demonstrated in our upcoming third quarter financial results,” said Aleafia Health CEO Geoffrey Benic. “Low-cost production will only strengthen our core business model of growing, producing, selling and exporting high-quality, value-added cannabis health and wellness products globally.”

2019 OUTDOOR HARVEST HIGHLIGHTS

  • 10,300 kg of dried flower harvested
  • 1,000 kg per acre yield in Zone 1, which was planted in June 2019
  • $0.08 cash cost per gram to harvest (unaudited)
  • $0.10 all-in cash cost per gram to harvest, including facility capital costs (five-year amortization) (unaudited)
  • Cannabinoid content (THC and CBD per gram) of harvested flower was strong, at levels near to the cannabinoid content in identical strains harvested indoor
  • Quality assurance testing to date is successful, including for microbial content, pesticides and contaminants

“Our inaugural 2019 outdoor harvest was successful due to the commitment and capabilities of our team. I’d like to thank our on-site growers who navigated the challenging environment of starting the cultivation season late into the year and ultimately delivered an excellent harvest that we are measuring in tons,” said SVP of Production Lucas Escott.

Total yield and 2020 projected yield figures are approximations. Cash cost per gram to harvest includes all operating expenses such as labour, supplies, consumables, services and staff overhead. All-in cash cost per gram to harvest includes all operating expenses, along with capital costs including irrigation, security infrastructure and the newly constructed Drying Facility.

As previously announced, Health Canada amended Aleafia Farms’ license to add Zone 1 to the site on June 7, 2019, with planting completed by Aleafia Farms within one week. Health Canada amended Aleafia Farms’ license to add Zone 2 to the site on July 12, 2019, with planting completed by Aleafia Farms over the last two weeks of July. The six acre Zone 1, benefiting from an earlier planting date, yielded 1,000 kg per acre.

Based on the 2019 results, the Company estimates that it can produce 1,200 kg per acre for a total of 102,000 kg of dried flower in 2020 at its expanded 3.7 million sq. ft. (86 acre) outdoor site, at full capacity. The modest increase in the expected yield per acre for 2020 is due a number of factors which should improve the overall outdoor grow operation, including commencing cultivation several weeks earlier relative to 2019.

The entire harvest was dried and cured on-site at the Company’s newly constructed and Health Canada-licensed Drying Building. The building comprises approximately 5,000 sq. ft. and features a 20 ft. high ceiling and a purpose-built climate control and dehumidification system to maximize throughput efficiency.

3.7M SQ. FT. OUTDOOR GROW PHASE II EXPANSION NEARING COMPLETION

On September 4, 2019, the Company announced that Aleafia Farms had acquired the farmland directly adjacent to its Port Perry facility, for a cash purchase price of $1.2 million. The expansion adds an additional 2.6 million sq. ft. (60 acres) of cultivation area, for a total of 3.7 million sq. ft (86 acres). Fencing and much of the security infrastructure at the expanded site has been completed and the Company expects to formally submit its Licence Amendment application in 2019.

For Investor and Media Relations, please contact:

Nicholas Bergamini, VP Investor Relations

1-833-TSX-ALEF (879-2533)

[email protected]

LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.

Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale, operational outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Cannabis Life Science